Literature DB >> 1167348

A comparison of glycosyltransferase activities and malignant properties in normal and transformed cells derived from BALB/c mice.

L M Patt, G A Van Nest, W J Grimes.   

Abstract

The ability of suspensions of BALB/c cells to catalyze the incorporation of nucleotide sugars into complex polysaccharides has been compared. These cells have previously been characterized for concanavalin A-induced agglutinability, tumorigenicity, and malignancy. All of the cell lines tested catalyze transfer of the sugar moieties of cytosine 5-monophosphate N-acetylneuraminic acid, uridine 5-diphosphate galactose, uridine 5-diphosphate N-acetylgalactosamine, uridine 5-diphosphate N-acetylglucosamine, uridine 5-diphosphate glucose, and guanidine 5-diphosphate monnose into glycoproteins and glycolipids. While some transformed lines exhibit alterations in transferase levels, others cannot be distinguished from normal cells. Normal cells, transformed cells that cause tumors that regress, and transformed cells that cause tumors that kill an immunologically competent host show growth-dependent changes in transferase activities. Determining the ability to catalyze carbohydrate transfer is insufficient for predicting the tumorigenic and malignant properties of a cell line.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1167348

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  2 in total

1.  A novel mechanism for isoprenaline-stimulated proliferation of rat parotid acinar cells involving the epidermal growth factor receptor and cell surface galactosyltransferase.

Authors:  K R Purushotham; W A Dunn; C A Schneyer; M G Humphreys-Beher
Journal:  Biochem J       Date:  1992-06-15       Impact factor: 3.857

2.  Sialyltransferase levels and sialic acid concentrations in sera of patients with malignant melanomas.

Authors:  W P Herrmann; W Gielen
Journal:  Arch Dermatol Res       Date:  1979-07-30       Impact factor: 3.017

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.